Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2.

Autor: Hagey RJ; ViRx@Stanford, Stanford Medicine, Stanford, CA, USA.; Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Elazar M; ViRx@Stanford, Stanford Medicine, Stanford, CA, USA.; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Pham EA; ViRx@Stanford, Stanford Medicine, Stanford, CA, USA.; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Tian S; Department of Biochemistry, Stanford University, Stanford, CA, USA., Ben-Avi L; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Bernardin-Souibgui C; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Yee MF; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Moreira FR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Rabinovitch MV; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Meganck RM; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Fram B; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Beck A; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA., Gibson SA; Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT, USA., Lam G; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Devera J; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Kladwang W; Department of Biochemistry, Stanford University, Stanford, CA, USA., Nguyen K; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Xiong A; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Schaffert S; Department of Medicine, Biomedical Informatics Research, Stanford University School of Medicine, Stanford, CA, USA., Avisar T; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Liu P; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Rustagi A; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA., Fichtenbaum CJ; Department of Internal Medicine, Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Pang PS; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA., Khatri P; Department of Medicine, Biomedical Informatics Research, Stanford University School of Medicine, Stanford, CA, USA., Tseng CT; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Center for Biodefense and Emerging Diseases, Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA., Taubenberger JK; Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Blish CA; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Hurst BL; Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT, USA., Sheahan TP; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Das R; Department of Biochemistry, Stanford University, Stanford, CA, USA.; Department of Physics, Stanford University, Stanford, CA, USA., Glenn JS; ViRx@Stanford, Stanford Medicine, Stanford, CA, USA. jeffrey.glenn@stanford.edu.; Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA. jeffrey.glenn@stanford.edu.; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA. jeffrey.glenn@stanford.edu.; Veterans Administration Medical Center, Palo Alto, CA, USA. jeffrey.glenn@stanford.edu.

Publikováno v: Nature medicine [Nat Med] 2022 Sep; Vol. 28 (9), pp. 1944-1955. Date of Electronic Publication: 2022 Aug 18.

Ionic Liquid Aqueous Two-Phase Systems for the Enhanced Paper-Based Detection of Transferrin and Escherichia coli .

Autor: Yee MF; Kamei Laboratory, UCLA, Department of Bioengineering, Los Angeles, CA, United States., Emmel GN; Kamei Laboratory, UCLA, Department of Bioengineering, Los Angeles, CA, United States., Yang EJ; Kamei Laboratory, UCLA, Department of Bioengineering, Los Angeles, CA, United States., Lee E; Kamei Laboratory, UCLA, Department of Bioengineering, Los Angeles, CA, United States., Paek JH; Kamei Laboratory, UCLA, Department of Bioengineering, Los Angeles, CA, United States., Wu BM; Wu Laboratory, UCLA, Department of Bioengineering, Los Angeles, CA, United States., Kamei DT; Kamei Laboratory, UCLA, Department of Bioengineering, Los Angeles, CA, United States.

Publikováno v: Frontiers in chemistry [Front Chem] 2018 Oct 16; Vol. 6, pp. 486. Date of Electronic Publication: 2018 Oct 16 (Print Publication: 2018).

A Combined Aqueous Two-Phase System and Spot-Test Platform for the Rapid Detection of Escherichia coli O157:H7 in Milk.

Autor: Cheung SF; 1 Department of Bioengineering, University of California, Los Angeles, CA, USA., Yee MF; 1 Department of Bioengineering, University of California, Los Angeles, CA, USA., Le NK; 1 Department of Bioengineering, University of California, Los Angeles, CA, USA., Gomes EA; 1 Department of Bioengineering, University of California, Los Angeles, CA, USA., Afrasiabi Z; 2 Department of Life and Physical Sciences, Lincoln University, Jefferson City, MO, USA.; 3 Math and Sciences, Soka University of America, Aliso Viejo, CA, USA., Kamei DT; 1 Department of Bioengineering, University of California, Los Angeles, CA, USA.

Publikováno v: SLAS technology [SLAS Technol] 2018 Feb; Vol. 23 (1), pp. 57-63. Date of Electronic Publication: 2017 Sep 25.

Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.

Autor: Cheng HK; KK Women's and Children Hospital, Singapore., Rajadurai VS, Amin Z, Sriram B, Yee MF, Han HH, Bock HL, Safary A

Publikováno v: The Southeast Asian journal of tropical medicine and public health [Southeast Asian J Trop Med Public Health] 2004 Sep; Vol. 35 (3), pp. 685-92.